In the second quarter, 10x Genomics ( TXG ) swung to a surprise profitability. Many were very encouraged by this, and I upgraded them from a sell to a hold , saying that while it I'm Jason Ditz and I have 20 years of experience in foreign policy research. My work has appeared in Forbes, Toronto Star, Minneapolis Star-Tribune, Providence Journal, Washington Times and the Detroit Free Press, as well as American Conservative Magazine and the Quincy Institute for Responsible Statecraft. I have been writing inve ...